Alignment of patient-clinician perspectives in triple-negative breast cancer (TNBC).

被引：0
|
作者：
Ackbarali, Tariqa
Goins, Chelsey
Walker, Stephanie
Donahue, Sara
Witt, Jennifer
Vidal, Gregory A.
Traina, Tiffany A.
机构：
[1] PlatformQ Hlth Educ, Needham, MA USA
[2] PlatformQ Hlth, Needham, MA USA
[3] MBC Alliance, Tarboro, NC USA
[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[5] Unity Point Hlth, Des Moines, IA USA
[6] Des Moines John Stoddard Canc Ctr, Des Moines, IA USA
[7] West Canc Ctr & Res Inst, Germantown, TN USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9032
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Analysis of the JAK2 gene in triple-negative breast cancer (TNBC)
    Stanek, L.
    Tesarova, P.
    Vocka, M.
    Petruzelka, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Prognostic role of stem cell markers in triple-negative breast cancer (TNBC)
    Song, J.
    Apple, S.
    Goodglick, L.
    Mah, V. H.
    Kim, S. R.
    Alavi, M. T.
    Chia, D.
    Deng, X.
    Chang, H. R.
    CANCER RESEARCH, 2013, 73
  • [23] Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
    Hoadley, Katherine A.
    Powell, Bradford C.
    Kanavy, Dona
    Marron, David
    Mose, Lisle E.
    Hyslop, Terry
    Berry, Donald A.
    Hahn, Olwen
    Tolaney, Sara M.
    Sikov, William M.
    Perou, Charles M.
    Carey, Lisa A.
    CANCER RESEARCH, 2020, 80 (04)
  • [24] Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)
    Mohd Mustafa
    Kashif Abbas
    Mudassir Alam
    Waleem Ahmad
    Nazura Moinuddin
    Shahid Ali Usmani
    Safia Siddiqui
    Molecular and Cellular Biochemistry, 2024, 479 : 895 - 913
  • [25] RADIOLOGICAL-HISTOLOGICAL SIZE CORRELATION IN TRIPLE-NEGATIVE BREAST CANCER (TNBC)
    Thibault, C.
    Gosset, M.
    Chamming'S, F.
    Lefrere-Belda, M.
    Pecuchet, N.
    Fournier, L.
    Roussel, H.
    Oudard, S.
    Lecuru, F.
    Medioni, J.
    ANNALS OF ONCOLOGY, 2014, 25
  • [26] Copper chaperons as novel targets for therapy in triple-negative breast cancer (TNBC)
    Karginova, O.
    Song, A.
    Wang, J.
    Luo, C.
    Jiang, H.
    He, C.
    Olopade, O. I.
    CANCER RESEARCH, 2016, 76
  • [27] Routinely applicable, highly multiplexed triple-negative breast cancer (TNBC) genotyping
    Kotoula, Vassiliki
    Papadopoulou, Kyriaki
    Charalambous, Elpida
    Zagouri, Flora
    Lakis, Sotiris
    Lymperopoulou, Angeliki
    Tsolaki, Eleftheria
    Pentheroudakis, George
    Lilakos, Kostas
    Pectasides, Dimitrios
    Fountzilas, George
    CANCER RESEARCH, 2014, 74 (19)
  • [28] A Phase II study of cabozantinib for metastatic triple-negative breast cancer (TNBC).
    Tolaney, Sara M.
    Ziehr, David R.
    Guo, Hao
    Barry, William Thomas
    Higgins, Michaela Jane
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena
    Paweletz, Cloud
    Demeo, Michelle
    Ramaiya, Nikhil H.
    Overmoyer, Beth
    Jain, Rakesh K.
    Duda, Dan G.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
    Chaudhuri, Aiswarya
    Kumar, Dulla Naveen
    Dehari, Deepa
    Singh, Sanjay
    Kumar, Pradeep
    Bolla, Pradeep Kumar
    Kumar, Dinesh
    Agrawal, Ashish Kumar
    PHARMACEUTICALS, 2022, 15 (05)
  • [30] The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
    Farghadani, Reyhaneh
    Naidu, Rakesh
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
12345